Skip to main content
← All Bills
SB372Senate

Provides relative to pharmacy benefit managers. (8/1/26)

Provides relative to pharmacy benefit managers. (8/1/26)

SponsorAdam Bass
StatusIntroduced
Last ActionMar 9, 2026
CommitteeInsurance
Pre-filed
Introduced
Committee
Floor
Passed
Signed
2026 Regular Session
Bill AnalysisAI Analysis
AI-generated summary · Updated Mar 3, 2026 · Not legal advice

Senate Bill 372 amends Louisiana Revised Statutes section 22:1870(D)(1) to expand the regulatory authority of the Commissioner of Insurance over pharmacy benefit managers. The bill retains existing requirements that pharmacy benefit managers submit annual transparency reports to the commissioner and that the commissioner may examine their books and records to verify report accuracy. The legislative change adds new authority permitting the commissioner to examine the books and records of any entity within a pharmacy benefit manager's corporate vertical integration structure, with the statute explicitly listing insurers, group purchasing organizations, manufacturers, wholesale distributors, special or mail order pharmacies, retail or long-term care pharmacies, and providers as examples of entities subject to examination.

The practical effect of this legislation extends regulatory scrutiny beyond individual pharmacy benefit managers to their affiliated corporate entities. Pharmacy benefit managers that operate vertically integrated structures encompassing insurance operations, drug distribution channels, or pharmacy services will now be subject to commissioner examination across all those affiliated components. This enables the commissioner to identify potential conflicts of interest, profit margins, and cost-shifting practices that may occur within corporate family structures where a single entity controls multiple functions in the pharmaceutical supply chain. Insurers, wholesalers, mail-order pharmacies, and retail pharmacies affiliated with a PBM will need to maintain records accessible for commissioner inspection and must cooperate with inquiries into their financial relationships with affiliated entities.

Senate Bill 372 operates within the existing statutory framework governing pharmacy benefit manager transparency established in R.S. 22:1870. The amendment enhances the commissioner's examination powers that were already present in subsection (D)(1)(a) but clarifies and expands the scope to encompassing affiliated entities in vertical structures. This aligns with Louisiana's insurance regulatory scheme where the commissioner possesses broad authority to examine insurance-related entities and their records. The provision addresses potential regulatory gaps where PBMs could previously argue that affiliated but technically separate entities fell outside the commissioner's direct examination authority, and the statute now explicitly establishes that corporate vertical integration structures do not shield subsidiary or affiliated entities from regulatory review.

AI-Generated Summary — For Reference Only. This summary was generated by artificial intelligence and may contain errors, misstatements, omissions, inconsistencies, or inaccuracies. It does not constitute legal advice and should not be relied upon as an authoritative interpretation of the bill or applicable law. Users should consult the official bill text, Louisiana Revised Statutes, and other primary legal authorities when forming any legal, regulatory, or policy conclusions. SessionSource assumes no liability for decisions made in reliance on AI-generated content.

Legislative History
Mar 9, 2026Senate
Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.
Feb 27, 2026Senate
Prefiled and under the rules provisionally referred to the Committee on Insurance.
Related News
Loading…
Bill Details
Bill NumberSB372
Session2026 Regular Session
ChamberSenate
TypeSenate Bill
StatusIntroduced
CommitteeInsurance
IntroducedFebruary 28, 2026
Last Action DateMarch 9, 2026
Last ActionIntroduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.
Sponsor & Authors
A
Primary Sponsor
Adam Bass
View profile →
My Watchlist
Loading...
Session Context
Session2026 Regular Session
ConvenesMarch 9, 2026
Sine DieJune 1, 2026 (6pm)
Day 42
of the 2026 regular session

SessionSource is an independent tracking tool not affiliated with the Louisiana Legislature. Information may be incomplete, delayed, or inconsistent with official records maintained by the Louisiana Legislature. Always verify legislative data at legis.la.gov. SessionSource does not warrant the accuracy or completeness of any information presented.

2026 SessionSource